Regencell Bioscience Holdings Ltd
(RGC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,584 | -4,363 | -6,062 | -7,595 | -1,347 |
| Depreciation Amortization | 78 | 306 | 293 | 150 | 27 |
| Other Working Capital | 19 | -585 | -509 | -1,024 | 553 |
| Other Operating Activity | 374 | 641 | 1,315 | 3,202 | 0 |
| Operating Cash Flow | $-3,114 | $-4,002 | $-4,963 | $-5,267 | $-767 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,839 | 5,248 | 85 | -10,000 | N/A |
| PPE Investments | -153 | -5 | -26 | -781 | N/A |
| Investing Cash Flow | $2,686 | $5,243 | $59 | $-10,781 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | -432 | 612 |
| Common Stock Issued | N/A | N/A | N/A | 22,674 | N/A |
| Other Financing Activity | 0 | 102 | 135 | 164 | -172 |
| Financing Cash Flow | $N/A | $102 | $135 | $22,406 | $440 |
| Exchange Rate Effect | -115 | 53 | -83 | N/A | N/A |
| Beginning Cash Position | 2,961 | 1,565 | 6,417 | 59 | 387 |
| End Cash Position | 2,419 | 2,961 | 1,565 | 6,417 | 59 |
| Net Cash Flow | $-542 | $1,396 | $-4,852 | $6,358 | $-328 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,114 | -4,002 | -4,963 | -5,267 | -767 |
| Capital Expenditure | -153 | -5 | -27 | -781 | N/A |
| Free Cash Flow | -3,266 | -4,007 | -4,990 | -6,048 | -767 |